Knowledge Center

Article / Jan 01, 2004

Selecting lactose for a capsule-based dry powder inhaler

Authors:
  • Hartwig Steckel
  • Fadi Eskandar
  • Peter Villax
Source:
Pharmaceutical Technology Europe (2004), 16(4), 23

Dry powder inhalers are a well-accepted dosage form for pulmonary drug delivery and a wide variety are either currently available or development. This article examines a premetered, capsule-based multidose inhaler for which different qualities of _-lactose monohydrate were screened.

Also in the Knowledge Center

Related Content

Global Sales and Marketing Meeting - GSM 2023

Hi there! Find here the relevant information about the Global Sales, Marketing & Communications and PMO Meeting in Lisbon, Portugal.

Page
Read more

Contact Us

Page
Read more

Our Policies

Our Policies (Quality, HSEE, Human Resources, Innovation & Entrepreneurship) communicate and document our values.

Page
Read more